Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda

dc.contributor.authorNakiyingi, Lydia
dc.contributor.authorKateete, David P.
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorWorodria, William
dc.contributor.authorSempa, Joseph B.
dc.contributor.authorAsiimwe, Benon B.
dc.contributor.authorKatabazi, Fred A.
dc.contributor.authorKatamba, Achilles
dc.contributor.authorHuang, Laurence
dc.contributor.authorJoloba, Moses L.
dc.contributor.authorMayanja-Kizza, Harriet
dc.date.accessioned2022-04-30T19:35:55Z
dc.date.available2022-04-30T19:35:55Z
dc.date.issued2012
dc.description.abstractNucleic acid amplification tests (NAATs) have offered hope for rapid diagnosis of tuberculosis (TB). However, their efficiency with smear-negative samples has not been widely studied in low income settings. Here, we evaluated in-house PCR assay for diagnosis of smear-negative TB using Lowenstein-Jensen (LJ) culture as the baseline test. Two hundred and five pulmonary TB (PTB) suspects with smear-negative sputum samples, admitted on a short stay emergency ward at Mulago Hospital in Kampala, Uganda, were enrolled. Two smear-negative sputum samples were obtained from each PTB suspect and processed simultaneously for identification of MTBC using in-house PCR and LJ culture. Results: Seventy two PTB suspects (35%, 72/205) were LJ culture positive while 128 (62.4%, 128/205) were PCR-positive. The sensitivity and specificity of in-house PCR for diagnosis of smear-negative PTB were 75% (95% CI 62.6-85.0) and 35.9% (95% CI 27.2-45.3), respectively. The positive and negative predictive values were 39% (95% CI 30.4-48.2) and 72.4% (95% CI 59.1-83.3), respectively, while the positive and negative likelihood ratios were 1.17 (95% CI 0.96-1.42) and 0.70 (95% CI 0.43-1.14), respectively. One hundred and seventeen LJ culturenegative suspects (75 PCR-positive and 42 PCR-negative) were enrolled for follow-up at 2 months. Of the PCR-positive suspects, 45 (60%, 45/75) were still alive, of whom 29 (64.4%, 29/45) returned for the follow-up visit; 15 (20%, 15/75) suspects died while another 15 (20%, 15/75) were lost to follow-up. Of the 42 PCR-negative suspects, 22 (52.4%, 22/42) were still alive, of whom 16 (72.7%, 16/22) returned for follow-up; 11 (26.2%, 11/42) died while nine (21.4%, 9/42) were lost to follow-up. Overall, more PCR-positive suspects were diagnosed with PTB during follow-up visits but the difference was not statistically significant (27.6%, 8/29 vs. 25%, 4/16, p = 0.9239). Furthermore, mortality was higher for the PCR-negative suspects but the difference was also not statistically significant (26.2% vs. 20% p = 0.7094). Conclusion: In-house PCR correlates poorly with LJ culture for diagnosis of smear-negative PTB. Therefore, in-house PCR may not be adopted as an alternative to LJ culture.en_US
dc.identifier.citationNakiyingi et al.: Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda. BMC Research Notes 2012 5:487. doi:10.1186/1756-0500-5-487en_US
dc.identifier.other10.1186/1756-0500-5-487
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/3068
dc.language.isoenen_US
dc.publisherBMC Research Notesen_US
dc.subjectPulmonary tuberculosisen_US
dc.subjectSmear-negative TBen_US
dc.subjectSmear-negative TBen_US
dc.subjectHIV-infecteden_US
dc.subjectHIV-TB co-infectionen_US
dc.subjectCD4 cell countsen_US
dc.subjectNucleic acid amplification testsen_US
dc.subjectIn-house PCRen_US
dc.subjectLowenstein-Jensen cultureen_US
dc.subjectSensitivity, Specificityen_US
dc.subjectResource limited settingsen_US
dc.titleEvaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Evaluation of in-house PCR for diagnosis of.pdf
Size:
354.06 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: